VAN DEN BOOGAARD, F. E., BRANDS, X., SCHULTZ, M. J., LEVI, M., ROELOFS, J. J. T. H., VAN 'T VEER, C., & VAN DER POLL, T. (2011). Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti‐inflammatory and antimicrobial effects in murine pneumococcal pneumonia. Journal of thrombosis and haemostasis, 9(1), 122-132. https://doi.org/10.1111/j.1538-7836.2010.04089.x
Citace podle Chicago (17th ed.)VAN DEN BOOGAARD, F. E., X. BRANDS, M. J. SCHULTZ, M. LEVI, J. J. T. H. ROELOFS, C. VAN 'T VEER, a T. VAN DER POLL. "Recombinant Human Tissue Factor Pathway Inhibitor Exerts Anticoagulant, Anti‐inflammatory and Antimicrobial Effects in Murine Pneumococcal Pneumonia." Journal of Thrombosis and Haemostasis 9, no. 1 (2011): 122-132. https://doi.org/10.1111/j.1538-7836.2010.04089.x.
Citace podle MLA (9th ed.)VAN DEN BOOGAARD, F. E., et al. "Recombinant Human Tissue Factor Pathway Inhibitor Exerts Anticoagulant, Anti‐inflammatory and Antimicrobial Effects in Murine Pneumococcal Pneumonia." Journal of Thrombosis and Haemostasis, vol. 9, no. 1, 2011, pp. 122-132, https://doi.org/10.1111/j.1538-7836.2010.04089.x.